fda warning letters compounding semaglutide september 2025 U.S. sends drug advertising to Lilly, Novo, Hims Compounded Semaglutide & Tirzepatide 2025:
Description
1 By preventing apoptosis, fostering synaptic regeneration, and supporting neuronal recovery, GLP-1 RAs may contribute to clinical improvement across a range of neurological disorders

Retatrutide might impact hormones and metabolism
Agcakaya E, Mutlu HH, Erbakan A, Sargin M

doi: 10.1089/jmf.2018.4182
